巴西不同行政区10价肺炎球菌结合疫苗对儿童肺炎住院率的影响
本研究为基于人群的生态学研究,分析巴西五个行政区20岁以下人群肺炎住院率在PCV10引入前(2003-2009)与后(2011-2017)的变化。结果显示总体肺炎住院率下降34.5%,但仅北部地区呈现指数下降模式(二次回归下降10.8%,p<0.01),且该地区0-4岁、5-9岁、10-14岁住院率显著下降。
要点
- 巴西整体肺炎住院率下降34.5%,但各地区趋势差异明显。
- 仅北部地区呈现与PCV10实施相关的指数下降(二次回归下降10.8%,p<0.01)。
- 北部地区0-4岁、5-9岁、10-14岁住院率分别下降12.5%、38.5%、10.7%。
核心结论
- 仅北部地区肺炎住院率下降趋势显著,可能与PCV10实施及HDI变化有关。
研究设计与样本
- 基于人群的生态学研究,数据来自巴西国家卫生系统医院信息系统(SIH-SUS)和巴西地理统计研究所,覆盖2003-2009年(暴露前)和2011-2017年(暴露后)20岁以下人群。
主要发现
- 总体肺炎住院率下降34.5%,哮喘和尿路感染住院率也呈类似趋势,各地区均观察到相同模式。
- 北部地区是唯一呈现指数发病率下降模式的地区(二次回归下降10.8%,p<0.01)。
- 仅北部地区0-4岁(-12.5%,p=0.01)、5-9岁(-38.5%,p<0.01)和10-14岁(-10.7%,p=0.03)住院率显著下降。
临床怎么用
- 在评估PCV10效果时需考虑地区社会经济差异,北部地区经验提示低HDI地区接种后可能获得更显著收益。
局限性
- 生态学研究设计无法推断个体因果,且未控制其他同时期干预措施。
- HDI在研究期间各地区演变不同,可能混杂疫苗效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Streptococcus pneumoniae is the most frequent bacterial causative agent of pneumonia. Due to its significant contribution to the morbidity and mortality profile and the country's economy, the 10-valent pneumococcal vaccine (PCV10) was introduced in Brazil in 2010. Brazil is divided into five administrative regions which differ in social-economic indices among each other. Estimates of PCV10 impact on hospitalization rates due to pneumonia stratified by distinct Brazilian regions are limited. We assessed this issue. METHODS: This is a population-based ecological investigation. Data about hospitalizations due to pneumonia, asthma or urinary tract infection (UTI) among patients aged under 20 years in the pre-exposure (2003-2009) and in the post-exposure (2011-2017) periods were retrieved from the National Health System - Hospital Information System (SIH-SUS) database. The total resident population by age group in each year was retrieved from the Brazilian Institute for Geography and Statistics database. Hospitalization rates were estimated for each Brazilian region and the rates obtained in the pre-exposure and in the post-exposure periods were compared by Prais-Winsten regression. The Human Development Index (HDI) evolved differently in the distinct regions during the study period. RESULTS: Overall, hospitalization rates due to pneumonia declined by 34.5%. Similar trends were observed for hospitalization rates due to asthma and UTI. The same pattern was observed in each Brazilian region. However, the North region was the only one that presented an exponential incidence decline pattern, which could be explained by PCV10 implementation (declined by 10.8% in the quadratic regression, p < 0.01). Only in the North region, significant decline was observed among patients aged 0-4 years (-12.5%; p = 0.01), 5-9 years (-38.5%; p < 0.01) or 10-14 years (-10.7%; p = 0.03). CONCLUSION: Significant variation in the downward trend of hospitalization rate was only found in the North region, which evolved from very low HDI in 2003; medium HDI in 2010 to high HDI in 2017.
引用
- Ferreira MN, Netto EM, Nascimento-Carvalho CM, et al. The impact of 10-valent pneumococcal conjugate vaccine upon hospitalization rate of children with pneumonia in different Brazilian administrative regions. Vaccine. 2021. PMID: 33726954. doi:10.1016/j.vaccine.2021.02.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。